Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 18;25(1):568.
doi: 10.1186/s12913-025-12656-2.

From awareness to integration: a qualitative interview study on the impact of digital therapeutics on physicians' practices in Germany

Affiliations

From awareness to integration: a qualitative interview study on the impact of digital therapeutics on physicians' practices in Germany

Jennifer Kendziorra et al. BMC Health Serv Res. .

Abstract

Background: The integration of digital therapeutics (DTx) into the German statutory healthcare system marks a significant shift in medical practice through the introduction of innovative, reimbursable digital interventions for patient care. While DTx can bridge therapy gaps and enhance patient care, the number of prescriptions is increasing slowly. This study aims to explore the challenges physicians face when integrating DTx into their treatment options and the changes this integration entails for their medical workflows.

Methods: A qualitative approach was adopted, gathering data from semi-structured interviews with 46 physicians across Germany. Participants, sampled for diversity in specialty, experience, and region, were interviewed between June 2022 and August 2024. The interviews explored physicians' knowledge, experiences, and perspectives on DTx. Data were analyzed using qualitative content analysis, combining deductive and inductive coding.

Results: The introduction of DTx into physicians' workflows impacts their practice on multiple levels. First, physicians must become aware of the new regulations and therapeutic possibilities, requiring significant information intake and time to feel adequately prepared for prescribing DTx. Second, DTx add complexity to patient assessment, as physicians must evaluate factors such as digital literacy, motivation, and cognitive conditions, necessitating a deeper understanding of their patients. Third, the integration of DTx reshapes the physician‒patient relationship, as it alters interaction dynamics, redistributes responsibilities, and poses new communication challenges. Fourth, DTx expand therapeutic options, particularly by bridging therapy delays and enabling more personalized care. Finally, the integration of DTx has the potential to drive long-term changes in physicians' workflows and mindsets, fostering alignment with multimodal and patient-centered treatment approaches.

Conclusions: DTx offer opportunities for patient care but also pose challenges, such as the development of digital skills or familiarization with new regulations, that necessitate adjustments in physicians' workflows. Physicians are generally confronted with an innovation that demands time, reliable information on effectiveness, practical experience, and openness to adopting digital health tools as complementary treatment options. However, the reception and integration of DTx into treatment vary among physicians, reflecting individual preferences and approaches. Further research should explore these diverse adoption strategies and examine the long-term effects of DTx on care delivery and patient outcomes.

Keywords: Digital health; Digital therapeutics; German healthcare system; Medical practices; Physician roles; Qualitative research.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study followed the ethical guidelines and regulations for qualitative studies and was performed in accordance with the Declaration of Helsinki. All participants were informed by the interviewers in advance about the purpose of the study. At the beginning of the interviews, all participants gave their informed consent to participate prior to data collection. According to the guidelines of the Joint Ethics Committee of the Universities of Bavaria (Gemeinsame Ethikkommission der Hochschulen Bayerns, GEHBa), no additional ethics committee review was required for this study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Alkhaldi O, McMillan B, Ainsworth J. Using the behaviour change wheel to develop a tailored intervention to overcome general practitioners’ perceived barriers to referring insomnia patients to digital therapeutic sleepio. BMC Health Serv Res. 2024;24:967. 10.1186/s12913-024-11384-3. - PMC - PubMed
    1. Allied Market Research. Digital Therapeutics Market by Product (Software and Devices), Sales Channel (Business-to-Business and Business-to-Consumers), Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS), Disease Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID) and Others: Global Opportunity Analysis and Industry Forecast, 2022–2031. 2021. Online available: https://www.alliedmarketresearch.com/digital-therapeutics-market.
    1. BfArM. Das Fast-Track-Verfahren für digitale Gesundheitsanwendungen (DiGA) nach § 139e SGB V. Ein Leitfaden für Hersteller, Leistungserbringer und Anwender. Version 3.5 vom 28.12.2023. 2023. Online available: https://www.bfarm.de/DE/Medizinprodukte/Aufgaben/DiGA-und-DiPA/DiGA/_nod....
    1. BfArM. Für Leistungserbringende. 2025. Online available: https://diga.bfarm.de/de/leistungserbringende.
    1. Carrera A, Manetti S, Lettieri E. Rewiring care delivery through digital therapeutics (DTx): a machine learning-enhanced assessment and development (M-LEAD) framework. BMC Health Serv Res. 2024;24:237. 10.1186/s12913-024-10702-z. - PMC - PubMed

LinkOut - more resources